Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Loblaw Companies Ltd Comments On FY 2013 Revenue Guidance; Reaffirms FY 2013 EBIT Guidance


Wednesday, 1 May 2013 06:30am EDT 

Loblaw Companies Ltd announced that for fiscal 2013, it expects sales growth to be moderated by a competitive environment characterized by ongoing square footage expansions, a new competitor's entry into the market and generic drug deflation. As a result, the Company continues to expect modest growth in operating income (EBIT) in fiscal 2013, excluding the impact of the $61 million restructuring charge recorded in the fourth quarter of 2012, the impact of the previously announced plan to launch an IPO of a new REIT and the $51 million gain recorded in the first quarter associated with amendments to certain defined benefit plans. The Company reported revenue of $31.604 billion and EBIT of $1.257 billion for fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $32.198 billion for fiscal 2013. 

Company Quote

55.58
0.05 +0.09%
15 Sep 2014